MedNest Incorporates and Launches Dermanest
MedNest incorporates and launches DermaNest as a wholly owned subsidiary. The mission of DermaNest is to commercialize develops the business of International Personalized Cosmetics and Skin-Care Solutions and Services for the US Markets.
February 26, 2012 (Newswire.com) - MedNest incorporates and launches DermaNest as a wholly owned subsidiary. The mission of DermaNest is to commercialize develops the business of International Personalized Cosmetics and Skin-Care Solutions and Services for the US Markets.
"There is a growing number of non-destructive and portable skin and wound imaging and diagnostic technologies that can enable a personalized approach to dermatology therapeutic programs and cosmetic products. Such solutions will enhance would and skin disease treatments and will take into accounts all aspect of skin. All combined, DermaNest is poised to be the catalyst of a personal approach to skin science." says Mathieu Petitjean, PhD, President of MedNest.
DermaNest already benefits from a remarkable track record of international clients and partners in this field developed by MedNest including SkinLabs, Agigma, Cytoo, LLTech, Une Fois un Jour among others. Such technologies have the potential to enhance the quality of the Research and Development of new therapies for skin diseases, or new actives compounds for the cosmetic market, in the same way personalized medicine is poised to revolutionize the approach and the business models related to healthcare. These technologies will focus not only on better characterizing various skin structures and variations but also look at the interactions of stimuli and compounds to the structure and how in turn the skin responds. Applications will include deposition, retention and penetration of actives; sensitization, irritation and photo-damage; wound healing; skin barrier functionality; and the moisturization, appearance and overall health of skin.
The DermaNest team offers a unique combination of highly experienced scientists and commercial leaders who will be focused on the development of relevant applications and value creation in the dermatology and cosmetic markets.
DermaNest's business model and highly experienced team empower early stage companies to play in high growth market segments, at a fraction of the cost of alternative solutions. Foreign companies who are interested to participate to the emerging growth of the personalized skin care and cosmetics in the US are invited to reach out to the DermaNest team (www.dermanest.com).
Categories: Business Technology